Details on the third patient have not been released, but Mr. Musk said in an interview streamed on X that all three humans with Neuralink implants are doing well.
Neuralink was implanted in the first human brain about a year ago. Mr. Musk said since then, the company has upgraded the device with more electrodes, higher bandwidth and longer battery life. The company plans to implant the device in 20 to 30 more people this year.
In November, Elon Musk got approval to conduct Neuralink’s first international clinical study.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
